NVision

Private

Ulm-based German quantum-tech company hyperpolarizing metabolic molecules to amplify MRI signals roughly 10,000x for real-time disease metabolism imaging. Expanding into quantum computing for drug design. Backed by Abbott as Series B anchor.

Founders Sella Brosh

CEO Sella Brosh

Company

Founded

2015

Headquarters

Ulm, Germany

Financials

Total Funding

$55M

Sectors

Healthtech Biotech Hardware

www.nvision-imaging.com

Funding History

1 round

Series B May 13, 2026

$55M

Abbott (Lead) Playground Global Matterwave Ventures b2venture Entrée Capital European Investment Bank

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.